PLX Annual Cost Of Goods Sold
$22.98 M
+$3.39 M+17.30%
31 December 2023
Summary:
As of January 22, 2025, PLX annual cost of goods sold is $22.98 million, with the most recent change of +$3.39 million (+17.30%) on December 31, 2023. During the last 3 years, it has risen by +$12.11 million (+111.37%). PLX annual cost of goods sold is now at all-time high.PLX Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLX Quarterly Cost Of Goods Sold
$8.38 M
-$1.08 M-11.43%
30 September 2024
Summary:
As of January 22, 2025, PLX quarterly cost of goods sold is $8.38 million, with the most recent change of -$1.08 million (-11.43%) on September 30, 2024. Over the past year, it has increased by +$3.48 million (+71.16%). PLX quarterly cost of goods sold is now -11.43% below its all-time high of $9.46 million, reached on June 30, 2024.PLX Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLX TTM Cost Of Goods Sold
$29.29 M
+$3.48 M+13.49%
30 September 2024
Summary:
As of January 22, 2025, PLX TTM cost of goods sold is $29.29 million, with the most recent change of +$3.48 million (+13.49%) on September 30, 2024. Over the past year, it has increased by +$12.77 million (+77.26%). PLX TTM cost of goods sold is now at all-time high.PLX TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLX Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.3% | +71.2% | +77.3% |
| 3 y3 years | +111.4% | +71.2% | +77.3% |
| 5 y5 years | +147.1% | +71.2% | +77.3% |
PLX Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.6% | -11.4% | +249.4% | at high | +79.2% |
| 5 y | 5-year | at high | +111.4% | -11.4% | +358.4% | at high | +169.4% |
| alltime | all time | at high | >+9999.0% | -11.4% | +222.3% | at high | +578.9% |
Protalix BioTherapeutics Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.38 M(-11.4%) | $29.29 M(+13.5%) |
| June 2024 | - | $9.46 M(+263.4%) | $25.81 M(+14.7%) |
| Mar 2024 | - | $2.60 M(-70.6%) | $22.50 M(-2.1%) |
| Dec 2023 | $22.98 M(+17.3%) | $8.86 M(+81.0%) | $22.98 M(+39.1%) |
| Sept 2023 | - | $4.89 M(-20.4%) | $16.52 M(-11.7%) |
| June 2023 | - | $6.15 M(+99.3%) | $18.70 M(+12.4%) |
| Mar 2023 | - | $3.08 M(+28.7%) | $16.64 M(-15.1%) |
| Dec 2022 | $19.59 M(+19.8%) | $2.40 M(-66.1%) | $19.59 M(-3.7%) |
| Sept 2022 | - | $7.07 M(+73.1%) | $20.34 M(+19.9%) |
| June 2022 | - | $4.09 M(-32.3%) | $16.97 M(-3.7%) |
| Mar 2022 | - | $6.03 M(+91.7%) | $17.62 M(+7.8%) |
| Dec 2021 | $16.35 M(+50.4%) | $3.15 M(-15.0%) | $16.35 M(+2.5%) |
| Sept 2021 | - | $3.70 M(-21.8%) | $15.95 M(+5.5%) |
| June 2021 | - | $4.73 M(-0.7%) | $15.12 M(+23.8%) |
| Mar 2021 | - | $4.76 M(+73.1%) | $12.21 M(+12.3%) |
| Dec 2020 | $10.87 M(-0.2%) | $2.75 M(-4.0%) | $10.87 M(-1.8%) |
| Sept 2020 | - | $2.87 M(+57.0%) | $11.07 M(-3.0%) |
| June 2020 | - | $1.83 M(-46.7%) | $11.41 M(-7.1%) |
| Mar 2020 | - | $3.43 M(+16.1%) | $12.28 M(+12.7%) |
| Dec 2019 | $10.89 M(+17.1%) | $2.95 M(-8.0%) | $10.89 M(+6.6%) |
| Sept 2019 | - | $3.21 M(+18.9%) | $10.22 M(+14.4%) |
| June 2019 | - | $2.69 M(+31.8%) | $8.94 M(+6.1%) |
| Mar 2019 | - | $2.04 M(-10.2%) | $8.42 M(-9.4%) |
| Dec 2018 | $9.30 M(-38.9%) | $2.28 M(+18.8%) | $9.30 M(+8.4%) |
| Sept 2018 | - | $1.92 M(-12.2%) | $8.58 M(-32.6%) |
| June 2018 | - | $2.18 M(-25.3%) | $12.73 M(-20.8%) |
| Mar 2018 | - | $2.92 M(+88.2%) | $16.07 M(+5.5%) |
| Dec 2017 | $15.23 M(+81.4%) | $1.55 M(-74.4%) | $15.23 M(-2.5%) |
| Sept 2017 | - | $6.07 M(+9.8%) | $15.63 M(+13.2%) |
| June 2017 | - | $5.52 M(+164.5%) | $13.81 M(+38.6%) |
| Mar 2017 | - | $2.09 M(+7.0%) | $9.96 M(+18.6%) |
| Dec 2016 | $8.40 M | $1.95 M(-54.0%) | $8.40 M(+30.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | $4.25 M(+153.6%) | $6.45 M(+166.3%) |
| June 2016 | - | $1.68 M(+220.3%) | $2.42 M(+149.3%) |
| Mar 2016 | - | $523.00 K(+134.5%) | $971.00 K(-115.9%) |
| Dec 2015 | $730.00 K(+15.9%) | - | - |
| Sept 2015 | - | $223.00 K(-0.9%) | -$6.12 M(+34.7%) |
| June 2015 | - | $225.00 K(-20.2%) | -$4.54 M(+43.7%) |
| Mar 2015 | - | $282.00 K(-104.1%) | -$3.16 M(-601.7%) |
| Dec 2014 | $630.00 K(-92.3%) | -$6.85 M(-480.8%) | $630.00 K(-82.5%) |
| Sept 2014 | - | $1.80 M(+12.0%) | $3.60 M(+6.2%) |
| June 2014 | - | $1.60 M(-60.6%) | $3.39 M(+9.3%) |
| Mar 2014 | - | $4.07 M(-205.1%) | $3.10 M(>+9900.0%) |
| Dec 2013 | - | -$3.88 M(-344.2%) | $0.00(-100.0%) |
| Sept 2013 | - | $1.59 M(+20.4%) | $5.05 M(-13.4%) |
| June 2013 | - | $1.32 M(+35.7%) | $5.83 M(-25.2%) |
| Mar 2013 | - | $971.00 K(-17.6%) | $7.79 M(-4.3%) |
| Dec 2012 | $8.14 M(+434.0%) | $1.18 M(-50.2%) | $8.14 M(+10.6%) |
| Sept 2012 | - | $2.37 M(-27.8%) | $7.36 M(+41.2%) |
| June 2012 | - | $3.28 M(+148.4%) | $5.21 M(+152.2%) |
| Mar 2012 | - | $1.32 M(+234.2%) | $2.07 M(+35.5%) |
| Dec 2011 | $1.52 M(-65.2%) | $395.00 K(+79.5%) | $1.52 M(-57.9%) |
| Sept 2011 | - | $220.00 K(+66.7%) | $3.63 M(-18.9%) |
| June 2011 | - | $132.00 K(-83.0%) | $4.47 M(+3.0%) |
| Mar 2011 | - | $778.00 K(-68.8%) | $4.34 M(+21.8%) |
| Dec 2010 | $4.38 M(+22.6%) | $2.50 M(+134.4%) | $3.56 M(-23.3%) |
| Sept 2010 | - | $1.06 M(-70.2%) | $4.64 M(+29.8%) |
| Dec 2009 | $3.58 M(>+9900.0%) | $3.58 M(>+9900.0%) | $3.58 M(+33.2%) |
| Dec 2005 | $35.00 K(-70.8%) | - | - |
| Dec 2004 | $120.00 K(-95.5%) | - | - |
| Dec 1999 | $2.68 M(-57.4%) | $23.50 K(-84.6%) | $2.68 M(+0.9%) |
| Sept 1999 | - | $152.70 K(-83.0%) | $2.66 M(+6.1%) |
| June 1999 | - | $896.60 K(-44.3%) | $2.51 M(+55.7%) |
| Mar 1999 | - | $1.61 M | $1.61 M |
| Dec 1998 | $6.31 M | - | - |
FAQ
- What is Protalix BioTherapeutics annual cost of goods sold?
- What is the all time high annual cost of goods sold for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual cost of goods sold year-on-year change?
- What is Protalix BioTherapeutics quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly cost of goods sold year-on-year change?
- What is Protalix BioTherapeutics TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics TTM cost of goods sold year-on-year change?
What is Protalix BioTherapeutics annual cost of goods sold?
The current annual cost of goods sold of PLX is $22.98 M
What is the all time high annual cost of goods sold for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual cost of goods sold is $22.98 M
What is Protalix BioTherapeutics annual cost of goods sold year-on-year change?
Over the past year, PLX annual cost of goods sold has changed by +$3.39 M (+17.30%)
What is Protalix BioTherapeutics quarterly cost of goods sold?
The current quarterly cost of goods sold of PLX is $8.38 M
What is the all time high quarterly cost of goods sold for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly cost of goods sold is $9.46 M
What is Protalix BioTherapeutics quarterly cost of goods sold year-on-year change?
Over the past year, PLX quarterly cost of goods sold has changed by +$3.48 M (+71.16%)
What is Protalix BioTherapeutics TTM cost of goods sold?
The current TTM cost of goods sold of PLX is $29.29 M
What is the all time high TTM cost of goods sold for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high TTM cost of goods sold is $29.29 M
What is Protalix BioTherapeutics TTM cost of goods sold year-on-year change?
Over the past year, PLX TTM cost of goods sold has changed by +$12.77 M (+77.26%)